But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection ...

Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply.

Exosome therapy is one of the most talked-about regenerative treatments today, but it sits firmly in the experimental zone ...

Get the latest Granules India share price today on NSE & BSE. Explore Granules India stock analysis, financial performance, market capitalization, dividend history, and future outlook for investors in ...

The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO) Wegovy weight-loss pill, the first of its kind. This once-daily tablet uses the same active ingredient — ...

Shield Therapeutics, which has a base in Gateshead, has secured an extension for its iron deficiency drug, meaning it can now ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (“Theralase®” or the “Company”), a clinical stage pharmaceutical company ...

In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears ...